Literature DB >> 1456259

An unusual presentation of medium-chain acyl coenzyme A dehydrogenase deficiency.

D Marsden1, K Sege-Petersen, W L Nyhan, W Roschinger, L Sweetman.   

Abstract

OBJECTIVE: To report an atypical presentation of medium-chain acyl Coenzyme A dehydrogenase deficiency in a 13-year-old girl with hyperammonemic encephalopathy and orotic aciduria meeting the accepted criteria for diagnosis of a female heterozygous for ornithine transcarbamylase deficiency.
DESIGN: Case report and definitive biochemical testing.
SETTING: Children's hospital and university laboratory. PARTICIPANT: One teenager.
INTERVENTIONS: Diagnosis and treatment with carnitine. MEASUREMENTS/MAIN
RESULTS: Assay ornithine transcarbamylase deficiency had normal results. The diagnosis was confirmed by DNA analysis, which revealed homozygosity for prevalent mutation (the adenine to guanine transition at position 985).
CONCLUSIONS: Patients with a clinical diagnosis of Reye's syndrome have, in general, an inborn error of metabolism. Medium-chain acyl Coenzyme A dehydrogenase deficiency and other disorders of fatty acid oxidation may present long after infancy. They may mimic the presentation of defects in the urea cycle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1456259     DOI: 10.1001/archpedi.1992.02160240069023

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

Review 1.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

2.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.

Authors:  B S Andresen; S F Dobrowolski; L O'Reilly; J Muenzer; S E McCandless; D M Frazier; S Udvari; P Bross; I Knudsen; R Banas; D H Chace; P Engel; E W Naylor; N Gregersen
Journal:  Am J Hum Genet       Date:  2001-05-08       Impact factor: 11.025

Review 3.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.

Authors:  Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  Biosci Rep       Date:  2015-11-20       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.